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Clinical data exercise angina in 30% of the patients, acute coronary syn-
droms in 61%, silent ischaemia in 7% and heart failure in 2%.
Procedural data all stents have been implanted under angiographic con-
trol, only 2 beeing imaged by IVUS, in de novo lesions, through a radial
approach with 6 French guiding catheters, following mandatory predilatation.
67% of patents had single vessel desease, 33% multivessel desease. Left ante-
rior descending artery was the target vessel in 64%, the left circumflex in 19%
and the right coronary artery in 26%. 212 stents have neen sdelivered with
only one failure. 25 patients underwent metallic stenting of other arteries. Side
branch angioplasty had to be performed in 4 cases. 
In hospital follow up No death. One complication withe non Q wave myo-
cardial infraction secondary to side branch occlusion (diagonal branch). One
transient ischaemic attack. 
Out hospital follow up at 22 months (12-27) no stent thrombosis occured.
One patient died of cranial traumatism; two patients (1%) had restenosis at
the margin of the BVS requiring repeated angioplasty. 
Conclusion at nearly two years follow up, our data confirm the safety of
the device and the low rate of reintervention.
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Background Although drug-eluting stents (DES) have been shown to dra-
matically reduce restenosis and improve the rate of event-free survival, the
benefit of DES appears to be limited to restenosis. In this retrospective, single-
center study we aimed to compare the long-term outcomes of DES versus
bare-metal stent (BMS) in large coronary arteries (diameter ≥3.5mm).
Methods A total of 164 consecutive patients (mean age 60 years) required
percutaneous coronary intervention with stents ≥3.5mm in diameter, 84 were
BMS and 80 DES. The primary endpoint was major adverse cardiac events
(MACE) defined as angiographically defined in-stent restenosis (ISR), stent
thrombosis and death from any cause.
Results A mean clinical follow up of 28 months was obtained. The DES
group had higher rates of diabetes (63% vs 37%, p=0.001), previous CAD
(74% vs 25%, p=0.001) and previous PCI (69% vs 31%, p=<0.04). There was
no significant difference between the two groups regarding the rate of hyper-
tension, dyslipidemia, smokers and the mean left ventricular ejection fraction.
There was a higher average stent length in the DES group (18.7 vs 16.3,
p=0.011) as well as a lower average stent diameter (3.54 vs 3.63, p=0.003).
There was a significant difference in MACE between the two groups in favour
of DES (11.3% DES vs 23.8% BMS group, p=0.04) at 28 months. The rate of
in-stent restenosis (ISR) was significantly reduced among patients receiving
DES with ISR rates of 15.8% among patients receiving DES compared to
41.7% among those receiving BMS (p=0.025). There were no significant dif-
ferences in the rate of death or stent thrombosis.
Conclusion In patients requiring stenting of large coronary arteries, there
was reduced MACE in patients treated with DES. This benefit was primarily
driven by decreased in-stent restenosis rate.
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Aims To demonstrate the acute and early outcomes of the Nile PAX dedi-
cated polymer-free paclitaxel-coated stents in the treatment of the coronary
bifurcation lesions. 
Methods and results The Nile PAX device incorporates a cobalt-chromium
alloy with a side aperture in the mid-stent designed to optimize scaffold at the
bifurcation carina and side branch (SB) ostium, while maintaining SB access
during procedure. From January 2012 to December 2014, 36 patients were
included in a retrospective, monocentric study. Lesion criteria were: vessel size
2.5-3.5mm in the parent vessel (PV) and 2.0-3.0mm in the SB, regardless of the
lesion length. Average age was 63,1 years, 22% of patientshad diabetesand 51%
had acute coronary syndrome, while LAD/Dg was involved in 67% of cases.
Percutaneous coronary intervention (PCI) Ad-Hoc was done for 40%of lesions.
SB received additional stent in 8% of procedures and final kissing-balloon infla-
tion was performed in 89% of procedures. There was three non-Q myocardial
infarctions: one during hospitalization, and two up to 6 months.In addition to
these three Major adverse cardiacevents (MACE), two other patients underwent
a target lesion revascularization due to astable angina.
Conclusions Preliminary results of this retro-prospective monocentric
study demonstrated encouraging results with the Nile PAX bifurcation DES in
the treatment of coronary bifurcation lesions, including high device and pro-
cedural success.
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Introduction Instent restenosis (ISR) remains the weak point of coronary
angioplasty despite the advent of drug-eluting stents.The drug eluting balloon
(DEB), which in contact of the artery wall releases an antiproliferative agent,
could be an option to treat ISR or some de novo lesions. 
Methods Between October 2013 and December 2014 in our center, all
patients treated with DEB for RIS or de novo lesions were identified. ISR was
defined as a stenosis of more than 50% or a measuring FFR≤0,8 to a site pre-
viously treated by stent. The lesion was first treated by compliant balloon then
DEB (SeQuent Please® laboratory Braun® B) was inflated for 30 seconds and
then removed. Angiographic control was achieved and, in case of incomplete
result or complication, a stent could be implanted.
Results Among the 48 patients treated with DEB, 23 were for ISR and 25
for de novo lesions. The average age of patients was 75.7 years. 31% of patients
were part of a long-term anticoagulation for atrial fibrillation. The clinical pre-
sentation was mostly a stable angina (62%). In 26% of ISR, there was in DES
restenosis, the average time of ISR was 2 years±3.9. The average diameter of
the DEB used was 2.4mm±0.4 for an average length of 17mm±4.7mm. For five
patients (10%) has a complement of stent implantation (DES in 60% of cases).
The double antiaggregation was continued during 3.8 months. In-hospital, one
death appeared. In the mean follow up of 6.5 months (maximum one year) no
deaths were reported. After revascularization 8% of patients had a clinical
relapse, 12.5% had a positive ischemic test. In 10.4% of cases, a significant rest-
enosis in angioplasty site DEB (TLR) has been highlighted, and requiring a new
revascularization.The average period for TLR was 7.6 months±4.
Conclusion The DEB is a safe option mainly for ISR and for small caliber
arteries, or bifurcation lesions or in the elderly or in long-term anticoagulation.
The clinical course is often satisfactory. 
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Objectives This work reports the concept and the practical feasibility of
Reversed Single String bifurcation stenting technique by demonstrating three
in vitro cases.
© Elsevier Masson SAS. All rights reserved.
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Background Provisional T stenting is the most used interventional tech-
nique to treat coronary bifurcation lesions. However, after main branch (MB)
stenting, treatment of the side branch (SM) becomes often indicated to provide
with good final result. Currently applied methods all have their morphologic
or structural limitations with respect to wall coverage, multiple strut layers,
apposition rate. We sought that reversing the Single String technique principle
may be used as a bail out for such clinical situations. This proof-of-concept
report describes and evaluates the procedure.
Methods and results We simulated in three silicone bifurcation phantoms
the scenario when stenting the SB becomes indicated after deployment of the
MB stent and performing kissing balloon dilatation. Thereafter, as first step of
Reversed Single String, a stent was positioned and deployed into the SB
ostium with one single protruding stent-cell into the MB. After wiring that
stent-cell and positioning MB balloon across it, final kissing balloon dilation
was performed. 
Result of the three in vitro Reversed Single String cases was evaluated by
X-ray and by optical frequency domain imaging and 3D reconstruction
(OFDI). Each case was performed successfully. In the bifurcation area perfect
apposition was documented in over 81% of the struts. Malapposition occurred
most frequently in area of neo-carina, but still remained below 4% of struts
for each case. 3D OFDI reconstruction did not reveal any strut fracture.
Conclusion This report suggests that Reversed Single String technique
might offer a potential bail out solution for provisional T-stenting cases, when
treatment of the SB becomes indicated.
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Introduction The RESCUe network registry monitors patients with STEMI
up to one year after the inceptive event. Follow up is done in coordination
with the general practitioner (GP). In this analysis of the database from July
2010 to November 2013, we looked at the impact of gender on High Authority
for Health (HAS) clinical practice indicators in STEMI patients. We analyzed
the characteristics and compliance with recommendations of prescriptions,
lifestyle recommendations and dietetic hygiene in 1422 patients followed by
their GP for at least one year. 
Results The percentage of men (75%) was stable in time. In STEMI,
women were significantly older than men (median age 74 years vs 60 years;
p<0.001), they were more likely to have hypertension (60% vs 40%; p<0.001)
and diabetes (20% vs 15%; ns) but less likely to be active smokers (22% vs
45%, p<0.001). 45% of them had a body mass index (BMI) <25 against 36%
of men. One year follow-up showed an equivalent prescription treatment in
men and women for betablockers (95% of beta-blockers in women vs 93% of
me), antiplatelet agents (99% vs 100%) and statins (96% vs 98%). 
Prescription of angiotensin converting enzyme inhibitors was lower in women
(87% of women vs. 94% of men (p<0.01)). Women presented more intolerance
than men (10.5% vs 5%). 28% of women underwent a cardiac rehabilitation pro-
gram vs 48% of men (p<0.001), 33% of them were physically active vs 56% of
men (p<0.001). 72% of women have benefited from lipid and glucose control vs
78% of men (p<0.05). Their diet was described as more balanced (79% vs 73%;
ns). In 94% of cases, the GP was in contact with the patient’s cardiologist.
Conclusion Some studies suggest a relationship to disease prevention and
gender. We found some differences to the detriment of women regarding car-
diac rehabilitation and physical activity. A thorough study of a larger cohort
is needed. Continuous information of health professionals on the risk of
gender bias should be pursued.
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Background Selenium plays an important role in the antioxidant defense
of myocardium both by being a part of enzyme glutathione peroxidase and
operating independently.
The Purpose of this research was to establish relation between serum sele-
nium levels and the biomarkers of cardiac injury in acute phase of myocardial
infarction.
Methods 42 patients with acute myocardial infarction (AMI) were examined,
mean age 61.82±7.65 years; 11 women, 31 men. The amounts of troponin I (TnI,
ng/mL) and creatine kinase-MB (CK-MB, U/L) were determined on admission
and in 24 hours. Selenium (Se) level was measured by fluorometric method. All
patients received standard therapy during first day of hospitalization. 
Results Se levels on admission and in 24 hours didn’t significantly differ
(0.225±0.03μg/mL and 0.219±0.04μg/mL, respectively). Close correlation was
established between initial Se levels and peak indexes of biomarkers: TnI (r=0.14,
p=0.006), CK-MB (r=0.16, p=0.004). Also, a positive correlation was found
between the peak amounts of biomarkers and the difference from initial to 24 h: TnI
(r=0.09, p=0.031), CK-MB (r=0.07, p=0.043). At the same time, initial Se levels
correlated negatively with the difference from initial to 24 h (r=–0.63, p=0.002).
Conclusion Se levels in acute phase of AMI closely correlate with the
peak amounts of cardiac biomarkers. Therefore, the changes of Se levels may
interrelate with the extent of myocardial injury during infarction.
The author hereby declares no conflict of interest
0089
Effect of combined occupational tasks on cardiovascular events: PRIME
study 
Yolande Esquirol* (1), John Yarnell (2), Jean Ferrieres (2), Jean-Bernard
Ruidavets (2), Frank Kee (2)
(1) Université Paul Sabatier, Toulouse, France – (2) UK Clinical Research
Collaboration, Belfast, Irlande
*Corresponding author: esquirol.y@chu-toulouse.fr (Yolande Esquirol)
Background Sedentary behaviour in leisure time or at home increases car-
diovascular risk, but it is uncertain whether this is also the case for occupa-
tional activity.
Purpose To investigate the qualitative and quantitative effects of different
types of occupational tasks and how they interacted together on incidence of
cardiovascular disease (CVD).
Methods The study included 7796 active middle aged European men from
the PRIME cohort. Using Cox proportional hazards analysis, and taking
account of anthropometric and biomedical factors, energy expenditure during
leisure time and commuting related physical activity, lifestyle habits and
social factors, the effects of time spent sitting or standing still, carrying objects
and walking at work were investigated to assess how they influenced the inci-
dence of CVD over 10 years’ of follow-up.
Abstract 0255 – Figure
